Robert Snijder
Overview
Explore the profile of Robert Snijder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Atzinger C, Arens H, Neri L, Arkossy O, Garbelli M, Jiletcovici A, et al.
Adv Ther
. 2024 Nov;
42(1):471-489.
PMID: 39581908
Introduction: Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) in patients with anaemia of chronic kidney disease may lead to increased ESA doses to achieve target haemoglobin levels; however, elevated doses may be...
2.
Lawlor A, Beyer K, Russell B, Steinbeisser C, Bjartell A, De Meulder B, et al.
Nat Rev Urol
. 2024 Sep;
22(2):116-124.
PMID: 39251785
Prostate Cancer Diagnosis and Treatment Enhancement through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer. PIONEER brings together...
3.
Rajwa P, Borkowetz A, Abbott T, Alberti A, Bjartell A, Brash J, et al.
Eur Urol Open Sci
. 2024 Apr;
63:81-88.
PMID: 38572301
Combination therapies in metastatic hormone-sensitive prostate cancer (mHSPC), which include the addition of an androgen receptor signaling inhibitor and/or docetaxel to androgen deprivation therapy, have been a game changer in...
4.
Rivas J, Nicoletti R, Ibanez L, Steinbeisser C, De Meulder B, Golozar A, et al.
Int J Surg Protoc
. 2023 Dec;
27(3):122-129.
PMID: 38046899
Androgen deprivation therapy-based with or without first-generation anti-androgens, was the standard of care for patients with metastatic hormone-sensitive prostate cancer (mHSPC) for decades. However, the development of docetaxel chemotherapy and...
5.
Gandaglia G, Pellegrino F, Golozar A, De Meulder B, Abbott T, Achtman A, et al.
Eur Urol
. 2023 Jul;
85(5):457-465.
PMID: 37414703
Background: Conservative management is an option for prostate cancer (PCa) patients either with the objective of delaying or even avoiding curative therapy, or to wait until palliative treatment is needed....
6.
Minutolo R, Grandaliano G, Di Rienzo P, Snijder R, Degli Esposti L, Perrone V, et al.
J Nephrol
. 2022 Nov;
36(2):347-357.
PMID: 36370331
Background: Limited data are available on the epidemiology and clinical management of anaemia in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). Methods: This retrospective observational study was based on records...
7.
Abiru N, Shoji S, Kosakai Y, Snijder R, Asakawa K, Rokuda M
Diabetes Res Clin Pract
. 2022 Jun;
190:109973.
PMID: 35760156
Aims: To investigate the baseline demographic and clinical characteristics of patients with type 1 diabetes mellitus (T1DM) newly treated with a sodium-glucose cotransporter 2 inhibitor (SGLT2i) as an add-on to...
8.
Kaneko Y, Sakurai M, Snijder R, Kokubo S, Kato D
Mod Rheumatol
. 2022 May;
33(3):448-459.
PMID: 35640001
Objectives: There is limited information on the clinical use of Janus kinase inhibitors (JAKis) for rheumatoid arthritis treatment in Japan. The aim of this study was to identify disease-modifying antirheumatic...
9.
Kimura T, Snijder R, Nozaki K
Kidney Int Rep
. 2020 May;
5(5):694-705.
PMID: 32405590
Introduction: Although early intervention for chronic kidney disease (CKD) and renal anemia are desirable, these conditions are often asymptomatic during their early stages and may be underdiagnosed. Methods: We retrospectively...
10.
Snijder R, Bosman B, Stroosma O, Agema M
Eur J Pediatr
. 2020 Apr;
179(10):1523-1528.
PMID: 32239291
This post hoc Poisson regression analysis investigated the relationship between mean volume voided and incontinence episodes/24 h after fixed frequency adjustment in children with overactive bladder from the LION study,...